<DOC>
	<DOC>NCT03049085</DOC>
	<brief_summary>Effect of Preoperative Aspirin in patients undergoing Off-pump Coronary Artery Bypass Grafting. A double-blind, placebo-controlled, randomized trial.</brief_summary>
	<brief_title>Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Eligible patients undergoing offpump coronary artery bypass grafting (OPCAB) Patients in whom antiplatelet therapy was stopped 57 days prior to OPCAB Patients undergoing onpump coronary artery bypass grafting Patients in whom antiplatelet therapy was not stopped 57 days prior to OPCAB Intraoperative conversion to onpump coronary artery bypass grafting Patients with inherited bloodclotting disorders Patients undergoing other cardiac operations</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>OPCAB</keyword>
	<keyword>ASA</keyword>
	<keyword>Aspirin</keyword>
</DOC>